This discovery provides additional evidence supporting the hypothesis of NDUFAF6 as a therapeutic target or predictive biomarker and offers new theoretical foundations and practical guidance for the diagnosis, treatment, and prognosis assessment of breast cancer. This evidence concerns the gene NDUFAF6 and breast cancer.